CARA logo

Cara Therapeutics (CARA) Non Current Assets

Annual Non Current Assets

$9.69 M
-$3.64 M-27.32%

31 December 2023

CARA Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$3.42 M
-$5.22 M-60.43%

30 September 2024

CARA Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CARA Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-27.3%-76.8%
3 y3 years-87.3%-93.6%
5 y5 years-57.3%-94.3%

CARA Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-87.3%at low-95.4%at low
5 y5 years-87.3%at low-95.5%at low
alltimeall time-87.3%+397.7%-95.5%+159.7%

Cara Therapeutics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$3.42 M(-60.4%)
June 2024
-
$8.64 M(-2.7%)
Mar 2024
-
$8.87 M(-8.4%)
Dec 2023
$116.16 M(-31.2%)
$9.69 M(-34.3%)
Sept 2023
-
$14.73 M(+52.6%)
June 2023
-
$9.65 M(-9.1%)
Mar 2023
-
$10.62 M(-20.3%)
Dec 2022
$168.91 M(-2.5%)
$13.33 M(-50.1%)
Sept 2022
-
$26.73 M(-47.0%)
June 2022
-
$50.41 M(-30.1%)
Mar 2022
-
$72.10 M(-2.3%)
Dec 2021
$173.29 M(-11.2%)
$73.77 M(+37.6%)
Sept 2021
-
$53.59 M(-5.9%)
June 2021
-
$56.98 M(-7.9%)
Mar 2021
-
$61.88 M(-18.7%)
Dec 2020
$195.06 M(+17.8%)
$76.09 M(+432.1%)
Sept 2020
-
$14.30 M(-46.4%)
June 2020
-
$26.70 M(-58.0%)
Mar 2020
-
$63.50 M(-5.6%)
Dec 2019
$165.66 M(-1.5%)
$67.30 M(+11.6%)
Sept 2019
-
$60.33 M(+142.6%)
June 2019
-
$24.87 M(-5.9%)
Mar 2019
-
$26.43 M(+16.5%)
DateAnnualQuarterly
Dec 2018
$168.14 M(+76.9%)
$22.68 M(+1623.7%)
Sept 2018
-
$1.32 M(-3.7%)
June 2018
-
$1.37 M(-25.0%)
Mar 2018
-
$1.82 M(-6.4%)
Dec 2017
$95.06 M(+54.7%)
$1.95 M(-6.0%)
Sept 2017
-
$2.07 M(-4.5%)
June 2017
-
$2.17 M(-4.4%)
Mar 2017
-
$2.27 M(-4.8%)
Dec 2016
$61.45 M(-43.6%)
$2.38 M(-24.0%)
Sept 2016
-
$3.13 M(+8.0%)
June 2016
-
$2.90 M(+14.3%)
Mar 2016
-
$2.54 M(+29.3%)
Dec 2015
$108.93 M(+105.0%)
$1.96 M(-11.5%)
Sept 2015
-
$2.22 M(-8.0%)
June 2015
-
$2.41 M(-7.2%)
Mar 2015
-
$2.60 M(-6.8%)
Dec 2014
$53.15 M(+265.1%)
$2.79 M(-6.0%)
Sept 2014
-
$2.96 M(-5.6%)
June 2014
-
$3.14 M(-5.7%)
Mar 2014
-
$3.33 M(-5.6%)
Dec 2013
$14.56 M(+1085.5%)
$3.52 M(-5.3%)
Sept 2013
-
$3.72 M(-13.6%)
Dec 2012
$1.23 M(-73.1%)
$4.31 M
Dec 2011
$4.56 M
-

FAQ

  • What is Cara Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Cara Therapeutics?
  • What is Cara Therapeutics annual non current assets year-on-year change?
  • What is Cara Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Cara Therapeutics?
  • What is Cara Therapeutics quarterly non current assets year-on-year change?

What is Cara Therapeutics annual long term assets?

The current annual non current assets of CARA is $9.69 M

What is the all time high annual non current assets for Cara Therapeutics?

Cara Therapeutics all-time high annual long term assets is $76.09 M

What is Cara Therapeutics annual non current assets year-on-year change?

Over the past year, CARA annual long term assets has changed by -$3.64 M (-27.32%)

What is Cara Therapeutics quarterly long term assets?

The current quarterly non current assets of CARA is $3.42 M

What is the all time high quarterly non current assets for Cara Therapeutics?

Cara Therapeutics all-time high quarterly long term assets is $76.09 M

What is Cara Therapeutics quarterly non current assets year-on-year change?

Over the past year, CARA quarterly long term assets has changed by -$11.32 M (-76.81%)